C5's European Market Access Think Tank

From Marketing Authorization to EU HTA and National Pricing Negotiations – Europe’s Rules are Changing C5’s European Market Access Think Tank is a new forum examining how legal, HTA, pricing, and reimbursement frameworks, reshaped by the EU HTA Act and the forthcoming Pharma Reform Package, are redefining access to medicines across the EU and UK. The event will provide practical insight into navigating approvals, IP, HTA, and national reimbursement systems to support successful market access and formulary placement.